Background: Romania has entered the pandemic fight in 26 February 2020 when the first positive case was identified (Inst. Cantacuzino, 27-feb-2020). Even from the beginning, in the first 6 months of pandemic, Marius Nasta Pneumology Institute received mostly moderate and severe covid-19 pneumonia patients. Results: A total of 602 SARS-Cov2 RT-PCR positive patients’ cases were analyzed. Among those patients, 46 (7,64%) were asymptomatic, 210 (34,88%) had mild, 168 (27,91%) had moderate and 178 (29,57%) had severe covid-19 disease. 226 (37,54%) patients had no known comorbidities, 227 (37,7%) had systemic hypertension, 118 (19,6%) had obesity, 115 (19,10%) had dibetes mellitus and 48 (7,97%) had a newly revealed hyperglycaemia, 106 (17,6%) had cardiac pathology and 50 patients (8,3%) had respiratory pathology. Among these patients, 143 (23,7%) had one comorbidity, 126 (20,93%) had two, 72 (11,96%) had three, 25 (4,15%) had four and 8 (1,32%) had 5 comorbidities. A binomial Generalized Linear Model (GLM) was built using R statistical software. Among clinical and laboratory factors which were evaluated, age (p=0.021), number of comorbidities (p/,0.001), and D-dimer (p<0.01), C reactive protein (p=0.038) and feritin levels (p<0.01) on the day of hospitalization were significantly associated with patient mortality. Conclusion: Increased age, number of comorbidities and cytokine-storm biomarkers levels were associated with mortality. A bioclinical score of risk could be computed to estimate the covid-19 disease prognosis and assign different classes of prognoses with optimal treatment to decrease mortality.